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Phagocytosis and autophagy are two important and
related arms of the host’s first-line defense against
microbial invasion. Rubicon is a RUN domain con-
taining cysteine-rich protein that functions as part
of a Beclin-1-Vps34-containing autophagy complex.
We report that Rubicon is also an essential, positive
regulator of the NADPH oxidase complex. Upon
microbial infection or Toll-like-receptor 2 (TLR2) acti-
vation, Rubicon interactswith the p22phox subunit of
the NADPH oxidase complex, facilitating its phago-
somal trafficking to induce a burst of reactive oxygen
species (ROS) and inflammatory cytokines. Conse-
quently, ectopic expression or depletion of Rubicon
profoundly affected ROS, inflammatory cytokine
production, and subsequent antimicrobial activity.
Rubicon’s actions in autophagy and in the NADPH
oxidase complex are functionally and genetically
separable, indicating that Rubicon functions in two
ancient innate immune machineries, autophagy and
phagocytosis, depending on the environmental
stimulus. Rubicon may thus be pivotal to generating
an optimal intracellular immune response against
microbial infection.
INTRODUCTION
Phagocytes play an essential role in host defenses against
microbial pathogens (Flannagan et al., 2009; Huang et al.,
2009; Lambeth, 2004; Sumimoto, 2008). The enzyme respon-
sible for superoxide anion production and, consequently,
reactive oxygen species (ROS) generation, is called the NADPH
oxidase or respiratory burst oxidase. Inactive in resting
macrophages and neutrophils, NADPH oxidase is activated by264 Cell Host & Microbe 11, 264–276, March 15, 2012 ª2012 Elsevieexposure to microorganisms or inflammatory mediators, result-
ing in nonmitochondrial production of ROS. The oxidase
consists of the common integral membrane protein subunit,
p22phox, and catalytic subunit gp91phox (NOX2), together
with the regulatory subunits p47phox, p40phox, p67phox and
the small GTPase Rac. ROS are themselves rapidly toxic and
can kill microbes, but they also participate in host defense by
inducing the activation of NF-kB and release of proinflammatory
mediators, such as IL-1a, IL-6, MCP-1, and TNFa. The impor-
tance of NADPH oxidase in host defenses is illustrated by
a life-threatening genetic disorder called chronic granulomatous
disease (CGD), in which the phagocyte enzyme is dysfunctional,
leading to life-threatening bacterial and fungal infections (Jones
et al., 2008; Martire et al., 2008; Matute et al., 2009; van den Berg
et al., 2009; Winkelstein et al., 2000).
Autophagy is an emerging host innate immune pathway that is
a highly regulated homeostatic process wherein worn-out
proteins, malfunctioning organelles, and invading microbes are
swept up and degraded by tiny ‘‘vacuum cleaners’’ (Deretic
and Klionsky, 2008; Deretic and Levine, 2009). Thus, autophagy
is an important innate safeguard mechanism for protecting the
organism against unwanted materials and guests and also for
keeping the organism healthy. Specifically, the autophagic
machinery functions in host defenses, called xenophagy, by
degrading invading pathogens, including intracellular bacteria
(e.g., Shigella flexneri and Mycobacterium tuberculosis), animal
viruses (e.g., alphaviruses and herpes virus), and plant viruses
(tobacco mosaic virus) (Kim et al., 2010; Orvedahl and Levine,
2009). Autophagy may protect infected cells by either enhancing
degradation of intracellular pathogens to blockmicrobial replica-
tion or by maintaining cellular nutrient status during periods of
microbial parasitism.
RUN domain protein as Beclin-1 interacting and cysteine-rich
containing (Rubicon) autophagy protein was recently identified
as a Beclin-1-binding partner that interacts through its coiled-
coil domains (Matsunaga et al., 2009; Zhong et al., 2009).
Rubicon contains a RUN domain, a serine-rich-N (SR-N) region,
a coiled-coil domain, a serine-rich-C (SR-C) region, and ar Inc.
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but not the autophagosome. Knockdown of Rubicon results in
a marked increase in the number of autolysosomes as well as
in receptor degradation, whereas its overexpression leads to
abnormal morphology of late endosome/lysosomes and the inhi-
bition of autophagosome/endosome maturation, suggesting
that Rubicon negatively regulates the maturation step of auto-
phagy and the endocytic pathway (Matsunaga et al., 2009;
Zhong et al., 2009). Furthermore, Rubicon interacts with Vps34
lipid kinase and Rab7 GTPase through its N-terminal RUN
domain and C-terminal cysteine-rich domain, respectively,
which ultimately controls Vps34 and Rab7 activity (Sun et al.,
2010, 2011; Tabata et al., 2010).
Phagocytosis and autophagy cooperate together as part of
the host’s first-line of immune defense against microbial inva-
sions (Huang et al., 2009; Sanjuan et al., 2007; Tal et al., 2009;
Travassos et al., 2010). Here, we report that Rubicon autophagy
protein is an essential positive regulator of the NADPH oxidase
complex, inducing ROS production upon microbial infection
or plasma TLR2 activation. Remarkably, Rubicon’s actions in
the Beclin-1-Vps34-containing autophagy complex and the
p22phox-gp91phox-containing NADPH oxidase complex are
functionally and genetically separable. Thus, Rubicon orches-
trates two innate immunemachineries, autophagy and phagocy-
tosis, to ultimately optimize the timing and efficiency of host
antimicrobicidal activity in response to specific environmental
stimuli.
RESULTS
Rubicon Interactionwith the p22phox-gp91phoxNADPH
Oxidase Complex
Because engaging the autophagy pathway via TLR signaling
enhances phagosome maturation and destruction of the
engulfedmicrobes (Sanjuan et al., 2007), we purified the radioac-
tively labeled Rubicon complexes from human THP-1 cells con-
taining vector or Flag-Rubicon upon stimulation with zymosan,
a TLR2 ligand (100 mg/ml), or rapamycin (2 mM). As previously
reported (Matsunaga et al., 2009; Zhong et al., 2009), Rubicon
(130K) was found to associate with several proteins, Vps15
(150K), Vps34 (110K), UVRAG (85K), and Beclin-1 (60K), based
on their molecular weights and coimmunoprecipitation (coIP)
(Figures 1A, S1A, and S1B). Besides this complex, Rubicon
also interacted with two additional proteins with the molecular
weights of 91K and 22K, and these interactions periodically
increased at 5 and 30 min after zymosan stimulation (Figure 1A
and S1B). In contrast, Rubicon interaction with the Beclin-1-
containing autophagy complex was not significantly affected
under zymosan-treatment conditions (Figures 1A and S1B).
Conversely, rapamycin stimulation detectably increased
Rubicon interactions with the Beclin-1-containing autophagy
complex without affecting its interactions with the 22K and 91K
proteins (Figure 1A and S1B). Yeast two-hybrid screens with
the full-length, N-terminal region (aa1-470) or C-terminal region
(aa471-972) of Rubicon as baits identified the p22phox integral
membrane subunit of the NADPH oxidase complex as a major
binding partner of Rubicon full-length or its C-terminal region.
Furthermore, mass spectrometry analysis of the purified
zymosan stimulation-induced Rubicon complexes determinedCell Hothat p22phox and gp91phox are the 22K and 91K proteins that
associated with Rubicon (Figure S1C). CoIP showed that
Rubicon interacted strongly with exogenous and endogenous
p22phox, and this interaction wasmore evident upon stimulation
with zymosan (Figures 1B and 1C). Binding studies with GST-
Rubicon mammalian fusions and GST-p22phox mammalian
fusions showed that Beclin-1 and p22phox efficiently bound
the central coiled-coil domain (CCD) (aa505-557) and the
C-terminal SR (aa558-625) of Rubicon, respectively, indicating
that the interactions of Rubicon with Beclin-1 and p22phox are
genetically separable (Figure 1D). Remarkably, the N-terminal
ten-amino acid sequence of p22phox directly and specifically
bound to a bacterially purified GST-Rubicon protein in vitro
because its mutant, W6AW9A, carrying the replacements of
tryptophan residues 6 and 9 with alanines, did not do so (Fig-
ure 1D). These results indicate that Rubicon directly interacts
with p22phox-gp91phox complex upon stimulation by zymosan.
Differential Rubicon Interaction Stabilizes p22phox
and gp91phox
To further delineate the temporal interaction profile of Rubicon,
Flag-Rubicon complexes were immunopurified upon zymosan
or rapamycin stimulation and immunoblotted with various anti-
bodies. This showed that Rubicon interactions with gp91phox
and p22phox periodically increased at 5 and 30 min after
zymosan stimulation, whereas its interactions with Beclin-1
and UVRAG were initially reduced (1–3 min) but immediately
recovered (Figures 2A and S1D). These interactions were
specific because the Rubicon DSR mutant lost the p22phox-
gp91phox interaction but retained the Beclin-1-UVRAG interac-
tion, whereas the DCCD mutant lost the Beclin-1-UVRAG
interaction but retained the periodic interaction with p22phox-
gp91phox (Figure 2A). In contrast, rapamycin stimulation might
not considerably alter Rubicon interaction with either the
Beclin-1-UVRAG complex or the p22phox-gp91phox complex
(Figure S2A). When the Flag-p22phox, Flag-gp91phox, or Flag-
p47phox complex was immunopurified, Rubicon interactions
with p22phox or gp91phox also peaked at 5 and 30 min after
zymosan stimulation, whereas Rubicon interaction with
p47phox was not detected (Figure S2B). Furthermore, Rubicon
interactions with p22phox or gp91phox were detected with
TLR2-mediated stimulation, but not intracellular soluble PMA-
induced stimulation (Figure S2C). These results indicate that
although Rubicon is primarily present in the Beclin-1-UVRAG
complex under normal and autophagy conditions, it is periodi-
cally recruited to the p22phox-gp91phox complex upon TLR2
activation.
In virtually all CGD patients with cytochrome b558 mutations,
neutrophils lack both gp91phox and p22phox, suggesting that
the formation of the p22phox-gp91phox heterodimer is impor-
tant for the stable expression of each subunit (Jones et al.,
2008; Malech and Hickstein, 2007; Martire et al., 2008; Matute
et al., 2009; van den Berg et al., 2009; Winkelstein et al., 2000).
We found that the expression or depletion of the Rubicon gene
markedly increased or decreased, respectively, the levels of
endogenous and exogenous p22phox and gp91phox expres-
sion, but not p47phox, in a binding-specific manner because
the DSR mutant did not do so (Figures 2B, S2D, S2E, and
S2F). Cycloheximide (CHX) treatment further confirmed thatst & Microbe 11, 264–276, March 15, 2012 ª2012 Elsevier Inc. 265
Figure 1. Rubicon Interaction with the p22phox-gp91phox NADPH Oxidase Complex
(A) Differential interactions of Rubicon with the Beclin-1-containing autophagy complex and the p22phox-gp91phox complex. Radioactively labeled THP-1 cells
containing vector or Flag-Rubicon were stimulated with zymosan or rapamycin for the indicated times, followed by IP with aFlag for autoradiography.
(B) Rubicon interaction with p22phox. At 48 hr posttransfection with Flag-Rubicon (left) or Flag-p22phox (right), Raw264.7 cells were stimulated with or without
zymosan for 30 min prior to immunoprecipitation (IP), followed by immunoblotting (IB).
(C) Rubicon interaction with p22phox. Raw264.7 and THP-1 cells were stimulated with zymosan for 30 min, followed by IP with ap22phox or aRubicon and IB.
(D) Binding mapping. Schematic diagram of Rubicon and p22phox. S-R, serine-rich; CCD, coiled-coil domain; C-R, cystein-rich; and TM, transmembrane (top).
At 48 hr posttransfection with mammalian GST or GST-Rubicon constructs together with V5-p22phox (left) or V5-Beclin-1 (right) or GST or GST-p22phox
constructs together with AU1-Rubicon (bottom left), 293T cells were used for GST pulldown, followed by IB with aV5, aGST or aAU1. (bottom right) Direct
interaction between Rubicon and p22phox. Bacterially purified GST-Rubicon SR-Cwas analyzed by Coomassie blue staining (left) or incubated with nickel beads
alone, WT p22phox (N-terminal 10aa)-6xHis or its mutant W6AW9A-6xHis to evaluate direct and specific binding, followed by IB with aGST (right). See also
Figure S1.
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Activation of Phagocytic NADPH Oxidase by RubiconRubicon expression significantly stabilizes p22phox level
(Figure 2C). The nmf333 mouse strain carrying the p22phox
Y121H mutation dramatically interferes with either the synthesis
or stability of the p22phox protein (Nakano et al., 2008). Remark-
ably, Rubicon also bound and stabilized the p22phox Y121H
mutant (Figure 2D). These findings suggest that Rubicon
effectively enhances p22phox stability in a binding-dependent
manner.266 Cell Host & Microbe 11, 264–276, March 15, 2012 ª2012 ElsevieRubicon Facilitates p22phox Phagosomal Localization
and Phagocytosis
We next examined the effect of Rubicon on p22phox localization
following infection with heat-killed (HK)-TRITC-labeled or live-
TRITC-labeled Listeria (L.)monocytogenes. Rubicon expression
apparently increased p22phox colocalization with HK or live-
TRITC-L.monocytogenes, aswell as the number of phagosomes
containing HK or live-TRITC-L. monocytogenes (Figures 3A,r Inc.
Figure 2. Rubicon Interaction Leads to p22phox-gp91phox Stabilization
(A) Differential Rubicon interactions. Raw264.7 cells containing vector, Flag-Rubicon WT or its mutant were stimulated with zymosan for the indicated times,
followed by IPwith aFlag and IBwith aBeclin-1, aUVRAG, agp91phox, ap22phox or aFlag. The right panels show the densitometry results of all three independent
coIP assays.
(B) (top) Rubicon-mediated increases of p22phox and gp91phox levels. THP-1 cells containing vector, Rubicon WT or DSR were stimulated with () or without
zymosan (+) for 18 hr and used for flow cytometry analysis to detect intracellular p22phox or surface expressing gp91phox. (bottom) IB with ap22phox,
agp91phox, aflag and aActin.
(C) Rubicon-mediated increases of p22phox and gp91phox stability. (left) Raw264.7 cells containing vector or Flag-Rubicon were stimulated with zymosan for
18 hr, followed by IB with ap22phox, agp91phox, aflag and aActin. (right) At 24 hr post-transfection with p22phox and/or Flag-Rubicon, 293T cells were treated
with solvent control (SC) or cyclohexamide (CHX, 1 mg/ml) for indicated times and cell lysates were used for IB with ap22phox and aActin. The bottom panel
shows the ratio of p22phox/Actin during CHX time course treatment.
(D) Analysis of p22phox Y121H mutant expression upon Rubicon expression. At 48 hr post-transfection with Flag-Rubicon and/or p22phoxWT or Y121H mutant,
293T cell lysates were used for IP with aFlag and IB with ap22phox. WCLs were used for IB with ap22phox, aFlag, or aActin. See also Figure S2.
Cell Host & Microbe
Activation of Phagocytic NADPH Oxidase by RubiconS3A, S3C, and S3D). Conversely, depletion of Rubicon expres-
sion not only suppressed p22phox colocalization with HK or
live-TRITC-L. monocytogenes, but also reduced phagosome
numbers (Figures 3A, S3B, S3C, and S3D). Expression of
Rubicon WT and DCCD markedly increased the numbers of
HK or live-TRITC-L. monocytogenes-positive phagosomes,
and both completely colocalized with p22phox (Figures 3B,
S3E, S3F, S3G, S3H, S3I, S3J, and S3K). In striking contrast,Cell Honot only did the Rubicon DSR mutant display diffuse cytosolic
staining, but it also apparently prevented p22phox from traf-
ficking into HK or live-TRITC-L. monocytogenes-positive phago-
somes (Figures 3B, S3H, S3I, S3J, and S3K). Furthermore, upon
time-course exposure to Texas red-labeled opsonized-zymosan
particles, Rubicon WT and DCCD extensively colocalized with
p22phox and gp91phox in the zymosan-particle-containing
phagosomes, and also significantly increased the phagosomest & Microbe 11, 264–276, March 15, 2012 ª2012 Elsevier Inc. 267
Figure 3. Rubicon Affects p22phox Phagosome Recruitment and Phagocytosis
(A–C) (A) Expression or depletion of Rubicon affects the colocalization of p22phox with L. monocytogenes-containing phagosomes. At 48 hr postinfection with
lenti-GFP or lenti-GFP-Rubicon (top) atMOI = 100 (Figure S3A) or with lenti-shRNA-NS or lenti-shRNA-Rubicon (bottom) atMOI = 50 (Figure S3B), Raw264.7 cells
were infected with HK-TRITC-labeled L. monocytogenes (MOI = 1) for 30min, followed by confocal microscopy with ap22phox. Bar, 2 mm. Rubicon enhances the
colocalization of p22phoxwith L. monocytogenes (B) or zymosan particles-containing phagosomes (C) in a p22phox-binding-dependent manner. Raw264.7 cells
containing vector, Rubicon WT, DCCD or DSR were infected with HK-GFP-L. monocytogenes (B) or Texas red-labeled opsonized-zymosan particles (C) for
30 min, followed confocal microscopy with ap22phox or aFlag. Bar, 2 mm.
(D) Rubicon enhances phagocytosis in a p22phox-binding-dependent manner. At 48 hr postinfection with recombinant Ad-Vector (MOI = 200), Ad-Rubicon
(MOI = 100), or Ad-shRubicon (MOI = 200) virus, Raw264.7 cells were stimulated with zymosan-coated particles for indicated times, followed by lysis and
sucrose-gradient ultracentrifugation to isolate the bead-containing phagosomal fractions. Phagosomal fractions were subjected to IB with aBeclin-1, aUVRAG,
agp91phox, ap22phox, ap47phox, aVPS34, aLC3 or aRubicon. WCL were used for IB with aRubicon or aActin. See also Figure S3.
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induced translocation of p22phox into phagosomes was
not observed upon expression of the Rubicon DSR mutant
(Figure 3C and S3L). Furthermore, when cells were treated with
zymosan and Lysotracker or with GFP-L. monocytogenes
infection and a self-quenched red BODIPY dye-conjugated
bovine albumin serum (DQ-Red BSA), Rubicon WT and DCCD
colocalized extensively with Lysotracker-positive compartments
or DQ-Red BSA-positive and GFP-L. monocytogenes-contain-
ing phagosomal compartments, respectively (Figures S3M
and S3N).
Previous studies have found that the Vps34 is responsible for
phosphatidylinositol 3-phosphate (PtdIns-3-P) synthesis and
essential for phagolysosome formation (Vieira et al., 2001), and
that it is also targeted and inhibited by Rubicon (Sun et al.,
2010, 2011; Tabata et al., 2010). To examine the effect of
Rubicon on phagosomal maturation upon zymosan stimulation,
we measured Vps34 activity using the p40(phox) PX–EGFP
fusion protein (Liang et al., 2008). Under normal conditions,268 Cell Host & Microbe 11, 264–276, March 15, 2012 ª2012 Elseviep40(phox) PX–EGFP was visible in Raw264.7-vector cells as
a few punctate structures reflecting the PtdIns-3-P-rich vesicles,
whereas the punctate numbers of p40(phox) PX–EGFP were
detectably low in Rubicon WT-, DCCD-, or DSR-expressing
Raw264.7 cells (Figure S3O). By striking contrast, the intensity
and number of p40(phox) PX–EGFP–stained vesicles increased
dramatically in vector-, Rubicon WT-, DCCD-, or DSR-express-
ing Raw264.7 cells upon zymosan treatment at similar levels
(Figure S3O). These results indicate that although Rubicon WT,
DCCD, and DSR suppress Vps34 activity under normal condi-
tions, they show little or no suppressive effects on Vps34 activity
under zymosan-treatment conditions. Finally, the levels of inter-
nalized GFP-L. monocytogenes increased by nearly 3- to 4-fold
upon Rubicon WT and DCCDmutant expression, but decreased
3- to 4-fold upon DSR mutant expression (Figure S4A).
To further delineate Rubicon’s actions in the phagosomal traf-
ficking of the p22phox-gp91phox-containing NADPH complex,
Raw246.7 cells were infected with Rubicon-overexpressing or
Rubicon-specific shRNA-mediated knockdown adenovirusesr Inc.
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knockdown lentiviruses and then stimulated with zymosan-
coated or IgG-coated beads for various times. The latex bead-
containing phagosome fractions were subsequently purified
by sucrose-step-gradient-ultracentrifugations. Under normal
conditions, Rubicon-p22phox-gp91phox was recruited to
phagosomes at kinetics similar to Beclin-1-UVRAG-Vps34.
Under Rubicon-overexpression conditions, Rubicon-p22phox-
gp91phox was recruited to phagosomes earlier (5 min of stimu-
lation) than Beclin-1-UVRAG-Vps34 (15 min). In contrast, under
Rubicon-depletion conditions, the phagosomal recruitment of
Rubicon-p22phox-gp91phox was delayed and dramatically
reduced, whereas the phagosomal recruitment of Beclin-1-
UVRAG-Vps34 was not affected (Figure 3D). Additionally, the
expression levels of Rubicon, p22phox, and gp91phox were
directly correlated with their phagosomal recruitment levels,
whereas p47phox was independently recruited to phagosomes
(Figure S4B). Finally, Rubicon’s effects were TLR2-signaling
specific because they were not detected upon IgG stimulation
(Figure S4C). These results collectively indicate that Rubicon
facilitates the phagosomal trafficking of the p22phox-gp91phox
complex in a binding-dependent manner, and that the Rubicon-
p22phox-gp91phox complex and the Beclin-1-UVRAG-Vps34
complex are independently recruited to phagosomes.
Rubicon Activates NADPH Oxidase Activity in
a p22phox-Binding-Dependent Manner
We next used the oxidative fluorescent dyes dihydroethidium
(DHE) and 5,6-chloromethyl-20,70-dichlorodihydrofluorescein
diacetate acetyl ester (CM-H2DCFDA) to detect O2
- and H2O2
production, respectively (Yang et al., 2009). Upon zymosan
stimulation, the fluorescent signal intensities attributed to
O2
- and H2O2 production increased profoundly in Rubicon-
expressing Raw264.7 and primary mouse bone marrow-
derived macrophage cells (BMDMs) compared to control cells
(Figures 4A and 4B). In contrast, the antioxidant N-acetyl-L-
cysteine (NAC) and the NADPH oxidase inhibitor diphenyliodo-
nium chloride (DPI) significantly attenuated Rubicon-induced
O2
- and H2O2 production, respectively (Figures 4A and 4B).
Additionally, Rubicon expression dramatically enhanced
NADPH oxidase activity in Raw264.7 and mouse BMDMs
upon stimulation with zymosan or bacterial lipoprotein (BLP),
or upon infection with L. monocytogenes (Figures 4C and
4D). The stimulatory effect of Rubicon on NADPH consumption
and phagocytosis was nearly abolished by pretreatment with
the NADPH oxidase inhibitors DPI and 4-(2-aminoethyl)
benzene-sulphonyl fluoride (AEBSF) (Figures 4D and S4D). By
contrast, no significant difference in the PMA, LPS-, hot-
alkali-depleted zymosan- or NOD2-recognizing muramyl dipep-
tide (MDP)-mediated release of ROS was detected between
vector- and Rubicon-expressing Raw264.7 cells (Figure S4E).
Furthermore, Rubicon expression increased TLR2 interaction
with p22phox-gp91phox and its trafficking into zymosan-
coated bead-containing phagosomes where Rubicon was
also localized (Figures S5A and S5B). This action was specific
because there was little or no effect on the TLR2-MyD88 inter-
action as well as MyD88 Y257 phosphorylation (Figure S5A)
(Laird et al., 2009). When A549 epithelial cells endogenously
expressing NOX4 but not gp91phox (NOX2) were subjectedCell Hoto stimulation with BLP (TLR2 ligand) or LPS (TLR4 ligand),
Rubicon interacted with the p22phox-NOX4-TLR4 complex as
previously shown (Park et al., 2004) and efficiently enhanced
LPS-induced NOX4 activity but showed no effect on BLP-
induced signaling activities (Figures S5C, S5D, and S5E), sug-
gesting that Rubicon targets p22phox, a common subunit of
NOX family, and thereby affects various TLR-NOX pathways.
Finally, expression of the Rubicon WT and DCCD, but not the
DSR mutant, detectably enhanced phosphorylation of p38
and IkB, degradation of IkB, and nuclear localization of the
NF-kB p65 subunit in Raw246.7 cells upon zymosan treatment;
however, there was no significant effect on the phosphorylation
of p42/44 MAPK and JNK (Figure 4E).
Rubicon’s Effect on ROS, Cytokine Production and
Antimicrobial Activity
NADPH oxidase signaling is known to regulate proinflammatory
cytokine expression (Fang, 2004). Rubicon expressing
Raw264.7 cells produced markedly higher amounts of TNF-
a and IL-6 than vector-containing control cells (Figure 4F).
Furthermore, lentivirus-mediated expression of Rubicon in
primary mouse BMDMs led to significant increases in TNF-
a and IL-6 production, whereas pretreatment with the inhibitors
DPI and AEBSF nearly abolished this stimulatory effect of
Rubicon on cytokine production (Figure 4F). No significant differ-
ence in the LPS-mediated activation of cytokine production was
detected under Rubicon-depletion or -overexpression condi-
tions (data not shown). Finally, the viability and growth rate of
intracellular L. monocytogenes and M. bovis BCG decreased
drastically in Rubicon-expressing Raw246.7, THP-1, and mouse
BMDM cells compared to vector-containing control cells (Fig-
ure 4G). Consistently, the shRNA-mediated reduction of endog-
enous Rubicon expression led to significant attenuation of
NADPH oxidase activity, ROS production, and proinflammatory
cytokine production (Figures 5A, 5B, and 5C) and, thereby, to
a marked reduction of bacterial killing activity against intracel-
lular L. monocytogenes and M. bovis BCG in Raw246.7 and
BMDM cells (Figure 5D).
Besides NADPH phagocyte oxidase pathways, IFN-g-induc-
ible nitric oxide synthase (iNOS) pathways, which generate
nitric oxide (NO) radicals, represent another important antimi-
crobial system in phagocytic cells (Fang, 2004). To compare
Rubicon’s effect on the TLR2 pathway versus the IFN-g-iNOS
pathway for microbial killing activity, Raw264.7 cells were stim-
ulated with IFN-g, zymosan, L. monocytogenes infection or in
combination. Rubicon expression led to only minimal differ-
ences in ROS and NO production upon IFN-g stimulation
(Figures S5F and S5G). By contrast, L. monocytogenes infec-
tion or zymosan stimulation produced significantly higher levels
of ROS and NO production in Rubicon-expressing cells than in
vector-containing cells (Figures S5F and S5G). The combina-
tion of IFN-g stimulation and L. monocytogenes infection or
IFN-g stimulation and zymosan produced even higher levels
of ROS and NO production in Raw246.7-Rubicon cells than in
Raw246.7-vector cells (Figures S5F and S5G). In addition, the
levels of antimicrobial activity correlated directly with ROS
and NO production (Figure S5H). These results indicate that
Rubicon is primarily involved in TLR2-mediated antimicrobial
activity.st & Microbe 11, 264–276, March 15, 2012 ª2012 Elsevier Inc. 269
Figure 4. Rubicon Activates NADPH Oxidase Activity in a p22phox-Binding-Dependent Manner
(A and B) Rubicon activates ROS production. Raw264.7 cells or BMDMs were incubated with 20 mM DPI (A) and 20 mM NAC (B) to detect O2
- and H2O2
production, respectively, with or without zymosan for 30 min. Live cells were washed with serum-free medium and imaged using a confocal microscope.
Bar, 10 mm.
(C) Luminometry of NADPH oxidase activity of Raw264.7 cells containing vector or Rubicon after treatment with zymosan or BLP, or infected with
L. monocytogenes (MOI = 1).
(D) Rubicon enhances NADPH oxidase activity. BMDMs infected with lenti-GFP or lenti-GFP-Rubiconwas analyzed for NADPH oxidase activity upon zymosan or
BLP treatment.
(E) Rubicon expression enhances downstream signaling. Raw264.7 cells containing vector, Rubicon or its mutants were stimulated with zymosan for the indi-
cated times and then subjected to IB with the phosphorylated and total forms of p38, p42/p44 MAPK, JNK, IkB-a, or Actin.
(F) Increase of cytokine production by Rubicon. (top) Raw264.7 cells containing vector or Rubicon were stimulated with zymosan for the indicated times and the
supernatants were analyzed for cytokine ELISA. (middle and bottom) BMDMs infected with lenti-GFP or lenti-GFP-Rubiconwere stimulated with zymosan or BLP
for 18 hr and the supernatants were subjected to cytokine ELISA.
(G) Rubicon enhances bacterial killing activity. Raw246.7, THP-1 or BMDMs containing vector or Rubicon were infected with L. monocytogenes (left) orM. bovis
BCG (right) at a MOI = 1 for the indicated times and then lysed to determine intracellular bacterial loads. CFU, colony-forming units. *p < 0.05; **p < 0.01; ***p <
0.001 compared with the vector control. All data above are the mean ± SD of values from three experiments. See also Figure S4.
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L. monocytogenes Infection
To assess whether the depletion or expression of Rubicon
affects in vivo host responses to infection with
L. monocytogenes, recombinant adenoviruses, Ad-vector, Ad-
shRubicon, and Ad-Rubicon, were injected intravenously via
the tail vein at a dose of 1 3 1013 pfu/mouse twice; at 1 day
postinfection,micewerechallenged intraperitoneallywith a lethal
bacterial dose (1 3 107 CFU per mouse, n = 23 mice per each270 Cell Host & Microbe 11, 264–276, March 15, 2012 ª2012 Elseviegroup) (Figures S6A and S6B). Mice infected with Ad-vector
showed a median survival of 6 days; mice infected with Ad-
shRubicon died detectably sooner (median survival, 4 days),
and mice infected with Ad-Rubicon showed a significantly de-
layed mortality rate (median survival, 8 days) and an increased
survival rate (40% survival) (Figure 6A). To determine whether
these effects were due to impaired or enhanced bacterial clear-
ance in the Rubicon-depleted or Rubicon-expressing mice,
respectively, we measured the bacterial loads, serum cytokiner Inc.
Figure 5. Rubicon’s Effect on ROS and Inflammatory Cytokine Production
(A and B) Depletion of Rubicon gene expression leads to the reduction of ROS production (A) and NADPH oxidase activity (B). At 48 hr post-infection with
lentivirus-shRNA-NS or lentivirus-shRNA-Rubicon (MOI = 50), Raw264.7 cells or BMDMs were analyzed for O2
- production upon zymosan treatment for 30 min
with or without pretreatment with DPI (A) or for NADPH oxidase activity (B) as described in Figure 4. Bar, 10 mm.
(C) Reduction of cytokine production by Rubicon gene depletion. At 48 hr postinfection with lentivirus-shRNA-NS or lentivirus-shRNA-Rubicon, Raw264.7 cells or
BMDMs were stimulated with zymosan, BLP, L. monocytogenes or M. bovis BCG for 18 hr, and the supernatants were analyzed for cytokine production using
ELISA.
(D) Rubicon gene depletion reduces bacterial killing activity. At 48 hr postinfection with lentivirus-shRNA-NS or lentivirus-shRNA-Rubicon, Raw264.7 cells or
BMDMs were infected with L. monocytogenes (top) orM. bovis BCG (bottom) at a MOI = 1 for indicated times and then lysed to determine intracellular bacterial
loads. **p < 0.01; ***p < 0.001 compared with the lentivirus-shRNA-NS culture. All data above are the mean ± SD of values from three experiments. See also
Figure S5.
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after infection with a lower bacterial dose (1 3 106 CFU per
mouse). Under these conditions, Rubicon-depleted mice or
Rubicon-expressing mice had 1,000-fold higher or 10- to
100-fold lower bacterial loads in both organs, respectively,
compared to mice infected with Ad-vector (Figure 6B). Corre-
lated with the bacterial loads, the serum levels of TNF-a and
IL-6 and the NADPH oxidase activity in splenocytes were lower
in Rubicon-depleted mice and higher in Rubicon-expressing
mice than in mice infected with Ad-vector (Figures 6C and 6D).
To further investigate Rubicon’s effect on in vivo host
responses to L. monocytogenes infection, we generated
double-SRA-rtTA/Flag-Rubicon transgenic mice that carry
both reverse tetracycline transactivator (rtTA) under the control
of macrophage-specific promoter, a modified human scavenger
receptor A (SRA) promoter (Pan et al., 2008), and Flag-tagged
Rubicon under the control of tetracycline-inducible promoter.
Immunoblot and confocal microscopy analyses of splenocytesCell Hoisolated from transgenic SRA-rtTA/Flag-Rubicon mice showed
the doxycycline-inducible, macrophage-specific expression of
Rubicon (Figures S6C and S6D). At 7 days post-treatment
with doxycycline, mice were subsequently challenged intrave-
nously with a lethal L. monocytogenes dose (1 3 107 CFU per
mouse, n = 6 mice per each group). Untreated SRA-rtTA/Flag-
Rubicon mice showed a median survival of 6 days, but
doxycycline-treated mice showed 60% survival rate (Figure 6E).
In addition, untreated mice had 100- to 300-fold higher
L. monocytogenes loads in spleen and liver, respectively,
compared to doxycycline-treated mice (Figure 6F). Correlated
with the L. monocytogenes loads, untreated mice showed
much lower serum TNF-a and IL-6 levels and less severe infec-
tion-induced splenomegaly and inflammation than doxycy-
cline-treated mice (Figures 6G, 6H, and S6E). These results
unambiguously show that host defenses against bacterial infec-
tion are substantially affected by the levels of Rubicon
expression.st & Microbe 11, 264–276, March 15, 2012 ª2012 Elsevier Inc. 271
Figure 6. Alteration of Rubicon Gene Expression Affects Mice Mortality after L. monocytogenes Infection
(A–D) At 48 hr post-injectionwith Ad-vector (13 1013 pfu/kg), Ad-shRubicon (13 1012 pfu/kg), or Ad-Rubicon (13 1013 pfu/kg) twice intravenously via the tail vein,
mice were infected with L. monocytogenes (13 107 CFU/mouse) andmortality wasmeasured for n = 23mice per group (A). Bacterial loads of infectedmice (n = 5
per group) in spleen and liver (B), serum cytokine levels (C) or splenocyte ROS levels (D) were determined at 5 days post-infection with L. monocytogenes (13 106
CFU/mouse).
(E–H) Doxycycline-inducible, macrophage-specific expression of Rubicon in SRA-rtTA mice. After 7 days of doxycycline treatment, mice were infected with
L. monocytogenes (13 107 CFU per mouse) andmortality wasmeasured for n = 6mice per group (E). L. monocytogenes loads of infectedmice (n = 6 per group) in
liver and spleen (F). Serum cytokine levels (G) or H&E staining (I) were determined at 6 days post-infection with L. monocytogenes (1 3 106 CFU/mouse). CFU,
colony-forming units. ***p < 0.001 compared with the doxycycline-off conditions. The data are the mean ± SD of values from three experiments. Bar, 200 mm. See
also Figure S6.
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TLR-Signaling-Mediated Autophagy
To further delineate Rubicon’s actions in the autophagy complex
and the NADPH complex, Raw264.7 cells expressing Rubicon
mutants were evaluated for their phagocytosis and autophagy
activities in comparison to those of cells expressing WT. The
DCCD mutant induced NADPH oxidase activity, ROS produc-
tion, proinflammatory cytokine production, and bacterial killing
activity as strongly as WT, whereas the expression of the DSR
or DCDD/SR mutants showed suppressive or no effects under
the same conditions (Figures 7A, 7B, and 7C). Expression of
the Rubicon WT or the DSR mutant, both capable of binding
Beclin-1, showed increased LC3-II and p62 protein levels upon
rapamycin treatment or starvation, indicating suppression of
autophagosome maturation step (Figure 7D). In contrast,
expression of the DCCD mutant, which lost its ability to bind
Beclin-1, showed no effect on autophagosome maturation, as
evidenced by similar levels of LC3-II and p62 protein compared
to vector control cells (Figure 7D). Contrastingly, Rubicon WT
and its mutants showed no suppressive effect on autophago-
some maturation with zymosan or BLP treatment or
L. monocytogenes infection, likely due to the dissociation of
Rubicon from the Beclin-1-UVRAG-containing autophagy
complex upon such treatments (Figure 7D). Consistently,
Rubicon expression specifically affected the levels of rapamy-
cin- but not zymosan-induced p62 degradation; treatment with
3-methyladenine or bafilomycin further enhanced Rubicon-
mediated suppression of the autophagosome maturation step
(Figure S7). These results indicate that Rubicon plays distinctive
roles in conventional and TLR-signaling-mediated autophagy,272 Cell Host & Microbe 11, 264–276, March 15, 2012 ª2012 Elsevieand that Rubicon’s actions in the Beclin-1-UVRAG-containing
autophagy complex and in the p22phox-gp91phox-containing
NADPH complex are functionally and genetically separable.
DISCUSSION
Phagocytes play an essential role in host defenses against
microbial pathogens (Flannagan et al., 2009; Huang et al.,
2009; Lambeth, 2004; Sumimoto, 2008). Additionally, auto-
phagy-mediated cytoprotective mechanisms sequester
invading pathogens for degradation. Here, we report that
Rubicon autophagy protein functions as a positive regulator of
the phagocytic NADPH oxidase complex to induce a ROS burst,
inflammatory cytokine production, and, thereby, potent antimi-
crobial activities.
Rubicon Interaction Induces the Stability of p22phox
and gp91phox
Expression or depletion of the Rubicon genemarkedly increased
or decreased, respectively, the levels of endogenous and exog-
enous p22phox and gp91phox expression in a binding-specific
manner. The p22phox Y121H substitution mutation discovered
in p22phox-deficient nmf333 mice does not diminish its mRNA
expression but interferes with either its protein synthesis or
stability (Nakano et al., 2008). Rubicon interaction also increased
the stability of this p22phox Y121H mutant. Rubicon interaction
may facilitate the protein folding and/or tight complex formation
of p22phox-gp91phox. It should also be noted that, because
p22phox is a common subunit of the NADPH oxidase (NOX)
family (Lambeth, 2004), Rubicon’s effect should not be limitedr Inc.
Figure 7. ROS-Mediated Bacterial Killing Activity is p22phox-Binding-Dependent
(A) Rubicon enhances ROS production in a p22phox-binding-dependent manner. Raw246.7 cells expressing vector, Rubicon WT, or mutants were used for O2
-
production (left) or for NADPH oxidase activity (right) with or without zymosan for 30 min, as described in Figure 4. Bar, 10 mm.
(B) Rubicon increases cytokine production. Raw264.7 cells containing vector, Rubicon WT or its mutant were stimulated with zymosan, L. monocytogenes, or
M. bovis BCG for 18 h and the supernatants were analyzed for cytokine ELISA.
(C) Rubicon enhances bacterial killing activity. Raw246.7 containing vector, RubiconWT or its mutant were infected with L. monocytogenes (left) orM. bovis BCG
(right) at a MOI = 1 for the indicated times and then lysed; intracellular bacteria were plated to determine CFU. The data are the mean ± SD of values from three
experiments. ***p < 0.001 compared with the vector control.
(D) Rubicon plays distinctive roles in conventional and TLR-signaling-mediated autophagy. Raw246.7 cells expressing vector, Rubicon WT, DCCD, or DSR
mutant were treatedwith rapamycin, starvation, zymosan, BLP or L.monocytogenes for indicated times and their cell lysates were used for IB with aLC3, ap62, or
aactin. See also Figure S7.
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various other NOX members. Rubicon plays a primary role in
the gp91phox-TLR2 pathway in THP-1, RAW264.7, and BMDM
cells where gp91phox, but not NOX4, is expressed. Conversely,
when human lung epithelial cells and umbilical vascular endothe-
lial cells expressing NOX4 but not gp91phox were subjected to
BLP or LPS stimulation, Rubicon interacted with the p22phox-
NOX4 complex. This interaction efficiently increased LPS-
induced NADPH oxidase but not BLP-induced NADPH oxidase
activity (Figures S5A, S5B, S5C, S5D, and S5E and unpublished
results), indicating that Rubicon targets p22phox, a common
subunit of the NOX family and, hence, affects various NOX path-
ways, depending on its expression profiles (Bedard and Krause,
2007).
Rubicon Interactions with Beclin-1 Autophagy Complex
and NADPH Oxidase Complex
Previous studies showed that TLR signaling usurps autophagy
components to increase the efficiency of phagocytosis, thereby
providing a potential link between these two ancient microbial
defense mechanisms (Huang et al., 2009; Sanjuan et al., 2007;Cell HoTal et al., 2009). We demonstrate that the stimulus-dependent
interactions of Rubicon with the Beclin-1-UVRAG-Vps34
autophagy complex and the NADPH oxidase complex appear
to be an important event for crosstalk between these two innate
immune machineries: Although Rubicon associates with the
Beclin-1-UVRAG-Vps34 containing autophagy complex under
normal conditions, it periodically interacts with p22phox of the
NADPH oxidase complex upon TLR activation. In contrast, rapa-
mycin stimulation might not considerably affect Rubicon interac-
tion with either the Beclin-1-UVRAG-Vps34 autophagy complex
or the p22phox-gp91phox NADPH oxidase complex. Consis-
tently, the Rubicon-p22phox-gp91phox complex and the Be-
clin-1-UVRAG-Vps34 complex are independently recruited to
phagosomes upon TLR simulation, with Rubicon-p22phox-
gp91phox recruited to phagosomes earlier (5 min of stimulation)
than Beclin-1-UVRAG-Vps34 (15 min). Therefore, the obvious
question is: what types of molecular mechanisms specifically
determine Rubicon’s interactions with the Beclin-1-UVRAG-
Vps34 autophagy complex or with the p22phox-gp91phox
NADPHoxidase complex? The fact that the C-terminal SR region
of Rubicon is sufficient for binding p22phox suggests thatst & Microbe 11, 264–276, March 15, 2012 ª2012 Elsevier Inc. 273
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or modifications of the Rubicon C-terminal SR region, leading
to its association with the p22phox-gp91phox complex. Detailed
biochemical studies will be necessary to provide evidence for or
against this hypothesis.
Rubicon-Mediated Increase of Phagosome Trafficking
of p22phox-g91phox Complex
We showed that Rubicon efficiently facilitates the phagosomal
trafficking of the p22phox-gp91phox complex in a binding-
dependent manner. Recent studies have shown that Rubicon
interacts with the Rab7 GTPase protein through its C-terminal
cysteine-rich domain (Sun et al., 2010). Because Rab7 regulates
membrane trafficking by cycling between inactive (i.e., GDP-
bound) and active (i.e., GTP-bound) states, the Rubicon-Rab7
interaction is likely involved in facilitating the phagosome recruit-
ment of the p22phox-gp91phox complex. Besides increasing
p22phox-gp91phox phagosome recruitment, Rubicon expres-
sion considerably enhanced phagocytosis, an event requiring
the coordination of multiple processes, including TLR2 signaling,
phagocytic uptake, and phagosomal formation/maturation. A
previous study (Yang et al., 2009) showed that gp91phox asso-
ciates with TLR2 in response to ligand stimulation or microbial
infection and that this association is required for efficient phago-
cytosis, ROS burst, and inflammatory cytokine production in
macrophages. In line with this, we showed that Rubicon not
only markedly enhanced p22phox-gp91phox stability, resulting
in increased p22phox-gp91phox interaction with TLR2, but
also robustly increased the recruitment of TLR2 to phagosomes
where Rubicon, p22phox, and gp91phox colocalized. Further-
more, these effects were completely abrogated by treatment
with the NADPH oxidase inhibitors, DPI or AEBSF, indicating
the important role of NADPH oxidase activity for phagocytosis.
Thus, Rubicon may affect various steps of the tightly interrelated
phagocytic processes, including the TLR signaling pathway and
phagosome trafficking. It should be also noted that besides
NADPH phagocyte oxidase pathways, IFN-g-inducible iNOS
pathways generating NO radicals represent another important
antimicrobial system in phagocytic cells (Fang, 2004). Particu-
larly, a recent study reported that, similar to Rubicon, a family
of IFN-g-inducible guanylate-binding protein (Gbp) (Kim et al.,
2011) restricts Listeria infection by recruiting gp91phox-
p22phox NADPH oxidase complex and autophagy effectors
(Atg4b and p62/Sqstm1) to the bacteria-containing autophago-
lysosomes. Although Rubicon expression contributed to only
minimal differences in ROS and NO production upon IFN-g stim-
ulation, further study is necessary to define themolecular roles of
Rubicon in NADPH phagocyte oxidase-mediated and IFN-g-
inducible iNOS-mediated antimicrobial pathways. Nevertheless,
these indicate that phagocytosis-mediated and xenophagy-
mediated microbicidal activity induced by signaling molecules
such as Rubicon andGbpmay ultimately provide host protection
against a broad spectrum of pathogens.
Rubicon Functions in Autophagy and Phagocytosis
Autophagy and phagocytosis have been shown to efficiently
collaborate to generate effective host responses against micro-
bial infections as part of host’s initial innate immunity (Deretic,
2011; Kim et al., 2010; Kumar and Rao, 2011; Levine et al.,274 Cell Host & Microbe 11, 264–276, March 15, 2012 ª2012 Elsevie2011). Based on previous and current studies, we hypothesize
that, due to its ability to bind the Beclin-1-UVRAG-Vps34 auto-
phagy complex and the p22phox-gp91phox NADPH complex
in a genetically separable manner, Rubicon targets two ancient
innate immune machineries, autophagy and phagocytosis, to
efficiently orchestrate intracellular antimicrobial responses.
Under normal conditions, Rubicon first functions as a gatekeeper
of autophagy by interacting with the Beclin-1-UVRAG-Vps34
complex to suppress the autophagy and endocytic maturation
step (Matsunaga et al., 2009; Zhong et al., 2009). Upon TLR stim-
ulation, however, Rubicon interacts with the NADPH oxidase
phagocytic complex, resulting in two potential events in a timely
and efficient fashion: 1) the stabilization and phagosomal recruit-
ment of the p22phox-gp91phox complex, thereby activating
NADPH oxidase activity to induce ROS-mediated oxidative mi-
crobicidal activity; and 2) the release of Beclin-1-UVRAG-
Vps34 lipid kinase complex from its suppression mode, allowing
it to move to phagosomes and ultimately induce phagosomal
maturation as a nonoxidative cytoprotective antimicrobial
activity. Furthermore, we have demonstrated in an accompa-
nying paper that Rubicon acts as a physiological brake for
CARD9-mediated immune responses in a stimulation-specific
manner (Yang et al., 2012 [accompanying paper, this issue of
Cell Host & Microbe]). These indicate that Rubicon is a multifac-
eted immune modulatory protein that regulates host innate
immune response. Future studies will be directed to under-
standing how Rubicon coordinates various innate resistance
machineries to generate an optimal intracellular immune milieu
for controlling microbial infection.
EXPERIMENTAL PROCEDURES
Measurement of Intracellular ROS and Determination of NADPH
Oxidase Activity
The oxidative fluorescent dyes DHE (1 mM) and CM-H2DCFDA (2 mM) were
used to detect O2
- and H2O2 production, respectively, using confocal micros-
copy and lucigenin (bis-N-methylacridinium nitrate, 5 3 106 M) chemilumi-
nescence assays to measure NADPH oxidase (Yang et al., 2009). The values
are expressed as relative light units per 1 3 105 cells.
Phagocytosis Assays
In brief, L. monocytogenes was fluorescently labeled with tetramethylrhod-
amine isothiocyanate (TRITC; Sigma) in 0.1 M carbonate (pH 9.5) and stored
at 4C. TRITC-labeled L. monocytogenes or GFP-L. monocytogenes
(108 CFU) were then used to infect cells in a 12-well plate for indicated times
at 37C. Partially attached, noningested bacteria were removed by 1 hr of
treatment with 50 mg/ml gentamycin, using trypan blue as a quenching agent
to exclude fluorescence from the cell surface. Samples were then fixed with
4% p-formaldehyde and analyzed using a laser-scanning confocal micros-
copy (Nikon Eclipse C1) or BD FACSCanto II (Becton Dickinson; minimum
10,000 cells per sample) to identify the proportion of cells associated with fluo-
rescent bacteria, used as a marker for phagocytosis.
Zymosan or TRITC-labeled opsonized-zymosan particles (Molecular
Probes) were fed to cells for indicated time periods, with brief centrifugation
upon zymosan addition to ensure particle contact with the cells. Cells were
lifted in PBS containing 1 mM EDTA, 1 mM sodium azide, and 2.4 U/ml
proteinase K (to remove bound but not internalized zymosan particles) prior
to analysis by confocal microscope or flow cytometry.
Phagosome Purification
Phagosomes were formed by the internalization of latex beads in culture
medium at 37C for the indicated times. Cells were then washed in PBS on
ice, disrupted in homogenization buffer (3 mM imidazole, pH 7.4, containingr Inc.
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tin, 1 mg/ml E-64, 1 mg/ml leupeptin, 1 mg/ml pepstatin) by nitrogen cavitation
for 20 min at 300 psi in a bomb (Parr Instrument) at 4C. After centrifugation at
1,500 rpm for 7 min to remove nuclei and unbroken cells, the supernatants
containing the latex bead-containing phagosomal compartments (LBC) were
subjected to stepwise sucrose gradient centrifugation. Centrifugation was
carried out at 24,000 rpm for 1 hr in a SW41 Beckman swinging rotor. The
LBC fractions were collected from the 10%/25% sucrose interface. The
collected LBC fractions were washed with PBS. The purity of the final LBC
fractions was evaluated by electron microscopy.
Quantification of L. monocytogenes or M. bovis BCG
Intracellular Growth
To ensure the reliable quantification of intracellular bacteria, colony-forming
unit (CFU) was utilized. Cells were infected for 1 hr with L. monocytogenes
or for 2 hr with M. bovis BCG at different MOIs and washed three times
with PBS, followed by incubation with a medium containing gentamycin
(50 mg/ml for L. monocytogenes) or amikacin (200 mg/ml, M. bovis BCG) for
1 hr. Fresh medium containing gentamycin (5 mg/ml) or amikacin (20 mg/ml)
was then used for time-course incubation. Finally, cells were harvested and
lysed with 0.3% saponin (Sigma-Aldrich) to release the intracellular bacteria,
and cell lysates were then resuspended vigorously, transferred to screw cap
tubes, and sonicated in a preheated 37C water bath sonicator (Elma) for
5 min. Aliquots of the sonicates were then diluted 10-fold in BHI broth
(for L. monocytogenes) or 7H9 medium (for M. bovis BCG). Four dilutions of
each sample were plated separately on BHI agar (for L. monocytogenes) or
7H10 agar (for M. bovis BCG) plates and incubated at 37C with for 1 day
(for L. monocytogenes) or 2–3 weeks (for M. bovis BCG).
Mice and Adenovirus Injection
Six-week-old female C57BL/6 mice were purchased from Charles River Labo-
ratories. All animals received care in compliance with the guidelines outlined in
the Guide for the Care and Use of Laboratory Animals. Recombinant adenovi-
ruses were thawed immediately before injection at 25C and diluted with saline
solution to a final volume of 100 ml per mouse. Mice were held down within
a restrainer and their tails were mildly heated with a heating lamp to achieve
vasodilatation. Adenoviruses were injected through the tail vein slowly with
a 30-gauge needle. After injection, mild pressure was applied at the spot of
injection until no bleeding was achieved to prevent the backflow of virus solu-
tion. For measurement of the bacterial burdens in liver and spleen, mice were
killed on day 5 after inoculation, organs were homogenized in PBS, and serial
dilutions of the homogenates were plated on BHI agar plates, with colonies
counted 24 hr later.
Rubicon/SRA-rtTA Mice
A transgenic mouse strain C3H.TgN(SRA–rtTA) expresses reverse tetracycline
transactivator (rtTA) under the control of macrophage-specific promoter,
a modified human scavenger receptor A (SRA) promoter. To make a Rubicon
transgene construct, Flag-tagged Rubicon was cloned into pTRE-Tight (Clon-
tech) between the AflII and XbaI sites. Recombinant pTRE-Flag-Rubicon DNA
was purified from agarose gel and introduced into fertilized C57BL/6 oocytes
by pronuclear injection. Offspring were genotyped by PCR with specific
primers. Transgene-bearing founder mice were backcrossed to the C57BL/6
mice. Transcription of the Rubicon transgene was confirmed by RT-PCR.
Homozygote transgenic mice were generated by intercrossing transgene-
positive animals and selecting for the transgene homozygotes, using PCR
analysis. Transgene expression was induced in compound heterozygous
animals and their littermates by replacing normal drinking water with 5%
sucrose water containing 0.2 g/l doxycycline. Doxycyline-treated water was
changed every 2 days. After 7 days of doxycycline treatment, mice were sacri-
ficed and tissues were analyzed for Rubicon expression.
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